These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Improved flow cytometric detection of donor-specific HLA class II antibodies by heat inactivation. Ta M; Scornik JC Transplantation; 2002 May; 73(10):1611-4. PubMed ID: 12042648 [TBL] [Abstract][Full Text] [Related]
11. Low Expression Loci and the Use of Pronase in Flow Cytometry Crossmatch. Silva C; Aires P; Santo P; Xavier P Transplant Proc; 2023; 55(6):1383-1389. PubMed ID: 37173263 [TBL] [Abstract][Full Text] [Related]
12. Reanalysis of the role of pronase treatment of B cells in the flow cytometric crossmatch assay: Fc receptor is not the primary target. Brown NK; Meade JR; Wang J; Marino SR Hum Immunol; 2017 Nov; 78(11-12):704-709. PubMed ID: 28987959 [TBL] [Abstract][Full Text] [Related]
13. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients. Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794 [TBL] [Abstract][Full Text] [Related]
15. CASE REPORT: Serial Cases of False-Positive Flow-Cytometry T Cell Crossmatch Associated With Anti-Blood Type Antibodies in Patients Undergoing ABO-Incompatible Kidney Transplantation. Hayashi A; Yamamoto I; Kawabe M; Kobayashi A; Ito M; Hotta K; Shinohara N; Tasaki T; Yokoo T; Iwami D Front Immunol; 2022; 13():862652. PubMed ID: 35359981 [TBL] [Abstract][Full Text] [Related]
16. Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab. Bearden CM; Agarwal A; Book BK; Sidner RA; Gebel HM; Bray RA; Pescovitz MD Hum Immunol; 2004 Aug; 65(8):803-9. PubMed ID: 15336781 [TBL] [Abstract][Full Text] [Related]
17. Development of data-driven models for the flow cytometric crossmatch. Weimer ET; Newhall KA Hum Immunol; 2019 Dec; 80(12):983-989. PubMed ID: 31530432 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation. Won DI; Jeong HD; Kim YL; Suh JS Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535 [TBL] [Abstract][Full Text] [Related]